Screener
Axsome Therapeutics AXSM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's shares (diluted)?
- Axsome Therapeutics (AXSM) reported shares (diluted) of 51.2M in Q1 2026.
- How has Axsome Therapeutics's shares (diluted) changed year-over-year?
- Axsome Therapeutics's shares (diluted) increased by 4.8% year-over-year, from 48.9M to 51.2M.
- What is the long-term trend for Axsome Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Axsome Therapeutics's shares (diluted) has grown at a 7.1% compound annual growth rate (CAGR), from 150.3M to 198.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Axsome Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude